Shares of medical-device makers fell Wednesday after some of the sector’s heavy hitters signaled ongoing struggles in top markets for orthopedic and heart devices, which face growth challenges and a persistent threat to product prices.
Second-quarter reports from Johnson & Johnson (JNJ) and Stryker Corp. (SYK) indicated the market for replacement hips and knees has hit a new speed bump, interrupting a post-recession recovery. Those companies also showed that spinal devices remain under pressure from declining prices and, in a potentially concerning turn, some pushback from insurers.
Heart-device maker Boston Scientific Corp. (BSX) posted better-than-expected results, fueled by a fast … **SUBSCRIPTION REQUIRED TO READ MORE**
